Search

everythinglearnresearchcommunity

for

Search:↓

All-trans retinoic acid causes hair loss by increasing TGF-β2 in hair follicle cells.

Older adults have a high rate of skin cancers like basal cell carcinoma and melanoma, mainly due to UV exposure and age.

TCDD speeds up skin barrier formation by increasing certain gene expressions.

Best hair growth results from combining finasteride and minoxidil.

After menopause, women lose a lot of skin collagen, but estrogen replacement might improve skin health.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Alopecia areata can cause unpredictable hair loss, and treatments like corticosteroids and minoxidil may help but have varying side effects.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Targeting abnormal lung fluid metabolism could reduce COVID-19 deaths and ventilator use.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

Exosomes can improve skin health and offer new treatments for skin repair and rejuvenation.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

Dermatoscopy and videodermatoscopy are useful and reliable for tracking treatment progress in various skin conditions.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.

Treat hair loss with finasteride, minoxidil, or surgery; consider side effects and severity.

Hair loss in mice starts with immune cells damaging hair roots before it becomes visible.

Eccrine sweat gland's clear cells likely cause excessive sweating in hyperhidrosis.

Marie Antoinette syndrome causes sudden hair whitening, but its exact cause is unknown.

No true link between AGA and insulin resistance, but coexistence may worsen AGA.